Targeting skeletal muscle lipid turnover and the balance between lipolysis, FA uptake, and mitochondrial function/fat oxidation may be an attractive strategy with which to improve insulin sensitivity in obesity and T2D. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.